[Biologic agents in COPD management]. / Place des biothérapies dans la BPCO.
Rev Mal Respir
; 41(2): 127-138, 2024 Feb.
Article
in Fr
| MEDLINE
| ID: mdl-38129268
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a frequently occurring disease entailing high morbidity and mortality, and relevant therapeutic resources are limited. As is the case with asthma, the current trend consists in the phenotyping of COPD patients so as to develop personalized medicine tailored to a given individual's inflammatory profile. The aim of this review is to summarize the role of biologic agents in the management of COPD, taking into consideration not only COPD pathophysiology, but also the previously published studies and the relatively encouraging prospects for the future.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Biological Products
/
Pulmonary Disease, Chronic Obstructive
Limits:
Humans
Language:
Fr
Journal:
Rev Mal Respir
/
Rev. mal. respir
/
Revue des maladies respiratoires
Year:
2024
Document type:
Article
Country of publication: